Novo Nordisk and Swedish academia Combine in autoimmune research
This article was originally published in Scrip
Executive Summary
Novo Nordisk and the Swedish university consortium Combine have entered into a research collaboration to develop novel therapies for the treatment of autoimmune diseases.